十一月 2025
- Home
- Karyopharm Therapeutics
十一月 2025的Karyopharm Therapeutics市场份额分析
Meet Karyopharm's management team and learn more about their experience and leadership in the pharmaceutical industry.
Karyopharm Therapeutics(包含公司地区分支机构)
查看更多网站流量和参与度信息- karyopharm.com
Karyopharm Therapeutics收入截至 十一月 2025为 100M - 200M
Karyopharm Therapeutics主要域名产生的收入
3 年中Karyopharm Therapeutics主要域名的收入
Karyopharm Therapeutics主要域名的收入
Karyopharm Therapeutics热门域名的总访问量
了解Karyopharm Therapeutics市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
Karyopharm Therapeutics热门域名的平均访问时长
分析Karyopharm Therapeutics参与度指标。
过去 3 个月的平均访问时长
子公司明细
Karyopharm Therapeutics热门域名的平均页面浏览量
了解Karyopharm Therapeutics如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
Karyopharm Therapeutics 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Karyopharm Therapeutics Inc attended event Piper Sandler 37th Annual Healthcare Conference on Dec 1st '25.NEWTON, Mass., Dec. 1, 2025 /PRNewswire/ - Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company's senior management team will participate at the Piper Sandler 37th Annual Healthcare Conference in a fireside chat on Thursday, December 4, 2025 at 10:30 a.m. ET in New York, NY.
十二月 1, 2025阅读更多
新闻Karyopharm Therapeutics Inc hired Lori Macomber as Executive Vice President, Chief Financial Officer and Treasurer on Jan 3rd '25.Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company pioneering novel cancer therapies, has appointed Lori Macomber as Executive Vice President, Chief Financial Officer and Treasurer, effective January 3, 2025.
一月 2, 2025阅读更多
新闻Karyopharm Therapeutics Inc hired Brendan Strong as Senior Vice President of Investor Relations and Corporate Communications on Dec 9th '24.NEWTON, Mass., Dec. 9, 2024 /PRNewswire/ - Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced the appointment of Brendan Strong as Senior Vice President of Investor Relations and Corporate Communications.
十二月 9, 2024阅读更多
查看 Karyopharm Therapeutics 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。